|
The Longevity Medical Research Fund "More Life, More Life Worth Living" |
|
LysoSENS Target DiseasesLysoSENS is the first and primary beneficiary of the funds raised by The Longevity Medical Research Fund. LysoSENS is a SENS initiative to tackle atherosclerosis and other diseases caused by the accumulation of normally substances in the body. Their strategy is to target build-up of usually-benign metabolic by-products that in sufficient quantity become precursors to age-related disease. Their first and most urgent target is atherosclerosis, since, with its role in stroke and heart disease, it kills more Americans each year than all cancers combined. Targets of this initiative can be grouped by pathogenesis.
AGE Crosslinks: |